GlassScriptPhysician profile
Todd Evan Benson, JR.
NPI 1467870774
$1,236.23
in general payments reported to CMS, 2019-2025
20 companies · $312 in 2025
The $312 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $124 · 2021: $44.52 · 2022: $45.61 · 2023: $96.85 · 2024: $284 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $284.61 | 2023-2025 | Azstarys |
| Tris Pharma INC | $160.70 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $156.35 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $85.25 | 2023-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $83.84 | 2019-2025 | Rotarix, Pediarix, Bexsero |
| Cranial Technologies, INC | $81.83 | 2019-2024 | Doc Band |
| Neos Therapeutics, LP | $66.14 | 2019 | |
| Pfizer INC. | $63.75 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $34.42 | 2025 | Jornay Pm |
| Kaleo, INC. | $29.07 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $27.96 | 2024 | Dupixent |
| Verrica Pharmaceuticals INC. | $24.82 | 2024 | Ycanth |
| Sobi, INC | $23.35 | 2019 | |
| Adlon Therapeutics L.P. | $22.72 | 2019-2021 | |
| Sanofi Pasteur INC. | $21.39 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.16 | 2025 | Vaxneuvance, Enflonsia, Rotateq |
| Genentech USA, INC. | $14.71 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.54 | 2025 | Zoryve |
| Phadia US INC. | $14.32 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.